Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF EQUITY

v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, shares (in shares) at Dec. 31, 2018     586,881,720 549,907          
Beginning balance at Dec. 31, 2018 $ 1,791,291 $ 0 $ 5,869 $ (1,791) $ 3,004,422 $ (926) $ (20,131) $ (1,197,078) $ 926
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity-based compensation expense 11,007       11,007        
Exercise of Common Stock options and warrants (in shares)     19,232            
Exercise of Common Stock options and warrants (3)       (3)        
2025 convertible notes including share lending arrangement (in shares)     29,250,000            
2025 convertible notes including share lending arrangement 50,852   $ 293   50,559        
Net income (loss) (202,575)             (202,575)  
Other comprehensive income (loss) (8,643)           (8,643)    
Ending balance, shares (in shares) at Sep. 30, 2019     616,150,952 549,907          
Ending balance at Sep. 30, 2019 1,641,929   $ 6,162 $ (1,791) 3,065,059   (28,774) (1,398,727)  
Beginning balance, shares (in shares) at Dec. 31, 2018     586,881,720 549,907          
Beginning balance at Dec. 31, 2018 1,791,291 0 $ 5,869 $ (1,791) 3,004,422 $ (926) (20,131) (1,197,078) 926
Ending balance, shares (in shares) at Dec. 31, 2019     670,378,701 549,907          
Ending balance at Dec. 31, 2019 $ 1,614,759 (1,342) $ 6,704 $ (1,791) 3,142,993   (22,070) (1,511,077) (1,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Beginning balance, shares (in shares) at Jun. 30, 2019     616,150,952 549,907          
Beginning balance at Jun. 30, 2019 $ 1,708,931   $ 6,162 $ (1,791) 3,061,631   (20,351) (1,336,720)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity-based compensation expense 3,428       3,428        
Net income (loss) (62,007)             (62,007)  
Other comprehensive income (loss) (8,423)           (8,423)    
Ending balance, shares (in shares) at Sep. 30, 2019     616,150,952 549,907          
Ending balance at Sep. 30, 2019 1,641,929   $ 6,162 $ (1,791) 3,065,059   (28,774) (1,398,727)  
Beginning balance, shares (in shares) at Dec. 31, 2019     670,378,701 549,907          
Beginning balance at Dec. 31, 2019 1,614,759 $ (1,342) $ 6,704 $ (1,791) 3,142,993   (22,070) (1,511,077) $ (1,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity-based compensation expense 6,777       6,777        
Exercise of Common Stock options and warrants (in shares)     171,500            
Exercise of Common Stock options and warrants 669   $ 2   667        
Net income (loss) (1,712)             (1,712)  
Other comprehensive income (loss) 4,619           4,619    
Ending balance, shares (in shares) at Sep. 30, 2020     670,550,201 549,907          
Ending balance at Sep. 30, 2020 1,623,770   $ 6,706 $ (1,791) 3,150,437   (17,451) (1,514,131)  
Beginning balance, shares (in shares) at Jun. 30, 2020     670,378,701 549,907          
Beginning balance at Jun. 30, 2020 1,588,343   $ 6,704 $ (1,791) 3,147,030   (25,752) (1,537,848)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity-based compensation expense 2,740       2,740        
Exercise of Common Stock options and warrants (in shares)     171,500            
Exercise of Common Stock options and warrants 669   $ 2   667        
Net income (loss) 23,717             23,717  
Other comprehensive income (loss) 8,301           8,301    
Ending balance, shares (in shares) at Sep. 30, 2020     670,550,201 549,907          
Ending balance at Sep. 30, 2020 $ 1,623,770   $ 6,706 $ (1,791) $ 3,150,437   $ (17,451) $ (1,514,131)